HSP90AA1 and cancer: Hsp90 and its co‐chaperones interact with client protein substrates, many of which modulate signal transduction processes, and therefore, dysregulation of Hsp90 can contribute to a wide array of diseases including cancer, neurodegeneration, and viral infection amongst others [5, 6, 7, 8, 9, 10, 11].